Susquehanna International Group
DFTX

Susquehanna International Group’s Definium Therapeutics DFTX Stock Holding History

Susquehanna International Group’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.09M Buy
216,200
+83,600
+63% +$1.42M ﹤0.01% 4618
2025
Q4 		$1.78M Sell
132,600
-113,200
-46% -$1.4M ﹤0.01% 5893
2025
Q3 		$2.9M Buy
245,800
+115,900
+89% +$1.08M ﹤0.01% 5044
2025
Q2 		$843K Buy
129,900
+49,900
+62% +$328K ﹤0.01% 7886
2025
Q1 		$468K Sell
80,000
-30,700
-28% -$220K ﹤0.01% 9041
2024
Q4 		$770K Buy
110,700
+20,300
+22% +$140K ﹤0.01% 7601
2024
Q3 		$514K Sell
90,400
-33,900
-27% -$236K ﹤0.01% 8399
2024
Q2 		$896K Buy
124,300
+20,800
+20% +$182K ﹤0.01% 6852
2024
Q1 		$973K Buy
103,500
+23,900
+30% +$136K ﹤0.01% 6982
2023
Q4 		$291K Buy
79,600
+24,800
+45% +$74.7K ﹤0.01% 9909
2023
Q3 		$172K Sell
54,800
-1,100
-2% -$4.52K ﹤0.01% 10401
2023
Q2 		$200K Buy
55,900
+17,600
+46% +$60.7K ﹤0.01% 10275
2023
Q1 		$121K Sell
38,300
-66,400
-63% -$221K ﹤0.01% 11115
2022
Q4 		$230K Sell
104,700
-201,200
-66% -$559K ﹤0.01% 9774
2022
Q3 		$1.07M Buy
305,900
+282,240
+1,193% +$2.71M ﹤0.01% 6469
2022
Q2 		$227K Sell
23,660
-10,813
-31% -$137K ﹤0.01% 10314
2022
Q1 		$574K Sell
34,473
-14,707
-30% -$255K ﹤0.01% 8620
2021
Q4 		$1.02M Buy
49,180
+1,607
+3% +$51.3K ﹤0.01% 7245
2021
Q3 		$1.66M Buy
47,573
+7,113
+18% +$308K ﹤0.01% 6237
2021
Q2 		$2.09M Buy
+40,460
New +$2.12M ﹤0.01% 5813

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Susquehanna International Group's DFTX Position: Q1 2026 in Review

Susquehanna International Group reduced its Definium Therapeutics (DFTX) stake by 83% in Q1 2026, selling an estimated $6.71M and leaving 81,456 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #6810.

Susquehanna International Group first reported a position in DFTX in Q2 2021 and has held it in 16 quarters since. The position peaked at $6.39M in Q4 2025. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Susquehanna International Group held 81,456 shares of Definium Therapeutics worth $1.54M as of Q1 2026.
  • Susquehanna International Group sold 395,656 Definium Therapeutics shares in Q1 2026, an estimated $6.71M.
  • Definium Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6810 holding.
  • Susquehanna International Group first reported a position in Definium Therapeutics in Q2 2021 and has held it in 16 quarters since.
  • Susquehanna International Group's Definium Therapeutics position peaked at $6.39M in Q4 2025.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.